The global polymerase chain reaction (PCR) market is experiencing robust growth, with its valuation estimated at $6.2 billion in 2024 and projected to reach $16 billion by 2034, achieving a compound annual growth rate (CAGR) of 10%. PCR, a cornerstone of molecular diagnostics, has transformed healthcare by enabling rapid and accurate detection of diseases. Drawing from FactMR’s market...